Godoi A, Reis Marques I, Padrão EMH, et al. Glucose control and psychosocial outcomes with use of automated insulin delivery for 12 to 96 weeks in type 1 diabetes: a meta-analysis of randomised controlled trials. Diabetol Metab Syndr 2023;15(1):190. https://doi.org/10.1186/s13098-023-01144-4

Lee TTM, Collett C, Bergford S, et al. Efficacy and mechanism evaluation. Automated closed-loop insulin delivery for the management of type 1 diabetes during pregnancy: the AiDAPT RCT. Southampton (UK): National Institute for Health and Care Research Copyright © 2024 Lee et al.; 2024. https://doi.org/10.3310/WCHZ4201

Crabtree TSJ, Griffin TP, Yap YW, et al. Hybrid closed-loop therapy in adults with type 1 diabetes and above-target HbA1c: a real-world observational study. Diabetes Care 2023;46(10):1831-8. https://doi.org/10.2337/dc23-0635

NICE technology appraisal guidance on hybrid closed-loop systems for managing blood glucose levels in type 1 diabetes.

Available at https://www.nice.org.uk/guidance/ta943 [Accessed 8 October 2024].

Hybrid closed loop technologies: 5-year implementation strategy (NHS England). Accessible at https://www.england.nhs.uk/long-read/hybrid-closed-loop-technologies-5-year-implementation-strategy/ [Accessed 8 October 2024].

ABCD DTN-UK Educational modules on hybrid closed loops (HCL). Available at https://abcd.care/dtn-education/hybrid-closed-loops [Accessed on 8 October 2024].

Diabetes Specialist Nurse Forum UK (2024). Hybrid closed loop (HCL) systems comparison chart (version 5.0). Available at https://www.diabetesspecialistnurseforumuk.co.uk/hcp-resources [Accessed 8 October 2024].

Hambling H, Wilmot EG, Liarakos AL. At a glance factsheet: hybrid closed-loop therapy. Diabetes & Primary Care 2024;26:19–22